Compare · NAII vs TLRY
NAII vs TLRY
Side-by-side comparison of Natural Alternatives International Inc. (NAII) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NAII and TLRY operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- TLRY is the larger of the two at $786.5M, about 47.6x NAII ($16.5M).
- Over the past year, NAII is down 10.3% and TLRY is up 41.0% - TLRY leads by 51.2 points.
- TLRY has been more active in the news (12 items in the past 4 weeks vs 1 for NAII).
- TLRY has more recent analyst coverage (14 ratings vs 0 for NAII).
- Company
- Natural Alternatives International Inc.
- Tilray Brands Inc.
- Price
- $2.71-1.09%
- $6.74-2.67%
- Market cap
- $16.5M
- $786.5M
- 1M return
- +0.00%
- -3.23%
- 1Y return
- -10.26%
- +40.96%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2018
- News (4w)
- 1
- 12
- Recent ratings
- 0
- 14
Natural Alternatives International Inc.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Tilray Brands Inc.
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Latest NAII
- CarnoSyn® Brands Launches CarnoSyn® 4X, a Next-Generation Beta-Alanine for Sports Performance
- Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by Natural Alternatives International Inc.
- SEC Form 4 filed by Natural Alternatives International Inc.
- President, COO, & Sec. Wolf Kenneth covered exercise/tax liability with 5,151 shares and was granted 15,000 shares, increasing direct ownership by 7% to 141,831 units (SEC Form 4)
- Director Dunn Alan G was granted 8,000 shares, increasing direct ownership by 9% to 99,211 units (SEC Form 4)
- Director Matherly Laura Kay was granted 8,000 shares, increasing direct ownership by 24% to 42,000 units (SEC Form 4)
- Director Ramanathan Guru was granted 8,000 shares, increasing direct ownership by 27% to 38,000 units (SEC Form 4)
- CEO/Chairman Ledoux Mark A bought $3,474 worth of shares (1,250 units at $2.78), increasing direct ownership by 0.79% to 160,221 units (SEC Form 4)
- CEO/Chairman Ledoux Mark A bought $2,820 worth of shares (1,000 units at $2.82), increasing direct ownership by 0.63% to 158,971 units (SEC Form 4)
Latest TLRY
- Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling
- BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer
- SEC Form 4 filed by Hopkinson David G.
- Tilray Brands Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 424B7 filed by Tilray Brands Inc.
- Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care
- SEC Form 424B5 filed by Tilray Brands Inc.
- Tilray Brands Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership
- Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities